NEST Executive Director: A One Woman Army
Executive Summary
The National Evaluation System for health Technology, which FDA officials have said will re-make device data collection in the US, is finally getting off the ground. Rachael Fleurence took the helm last month as the executive director for the NEST Coordinating Center. In a podcast interview with Medtech Insight, Fleurence talks about her qualifications, and what she hopes the project will accomplish within the next year, and beyond.
You may also be interested in...
New HHS Chief Alex Azar Supports LDT Regulation, Cost-Saving Bundles
Alex Azar was confirmed as the next secretary of Health and Human Services with strong industry support. Azar comes to the role with some homework to do on key FDA medtech policies, but has expressed support for risk-based regulation of lab-developed tests and cost-saving bundled-payment models.
US Senators Press Agency Witnesses On Adding UDIs To Claims Forms
Democratic Sens. Patty Murray and Elizabeth Warren pressed US CMS and HHS officials at a recent hearing on making certain a line is added to Medicare claims forms for unique device identifiers, both to reduce Medicare costs and improve patient safety.
Applying Real-World Device Data: US FDA Finalizes Its Thoughts
The agency issued a final guidance spelling out reasonable applications of real-world device evidence and what factors must be considered when weighing whether data collected from routine care via means – such as electronic patient records or insurance claims – can help support a product approval or other regulatory decision.